Table 1. Baseline characteristics of patients included in this study.
| Characteristics | PPK model group | PPK validation group |
|---|---|---|
| Patient data | ||
| No patients | 311 | 50 |
| Gender (male: female) | 160:151 | 27:23 |
| Mean age (years) (range) | 6.34 (0.5–14) | 5.78 (1.5–13) |
| Mean weight (kg) (range) | 25.17 (5–70) | 21.77 (11–35) |
| Mean dosage (mg/d) (range) | 655.17 (250–2000) | 529.17 (250–1000) |
| Sample data | ||
| Mean sampling time (h) (range) | 7.35 (0.1–13) | 11.01 (10–12) |
| Total no. concentration-time points | 368 | 50 |
| Mean dose (mg·kg−1·d−1) (range) | 35.7 (5.1–62.5) | 31.4 (10–50.7) |
| Mean LEV concentration (μg/mL) (range) | 27.99 (4.85–116.11) | 25.11 (11.27–60.88) |